Clinical Trials
4 trialsNCT06627647 2026-05-22
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
AstraZeneca
Phase 3 Recruiting
NCT07178795 2025-11-17
A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT03329911 2021-09-14
A Comparative Study of BAT1706 and EU AvastinĀ® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer
Bio-Thera Solutions
Phase 3 Completed
NCT03169335 2018-08-24
Efficacy and Safety of QL1101 and AvastinĀ® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3 Completed